Fatemeh Zare Bozorgabadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fatemeh Zare Bozorgabadi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Akram Seifollahi
Department of Pathology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Fahimeh Azizinik
Advanced Diagnostic and Interventional Radiology Research Center (ADIR) Tehran University of Medical Sciences Tehran Iran
1 shared publication - Fatemeh Shakki Katouli
Advanced Diagnostic and Interventional Radiology Research Center (ADIR) Tehran University of Medical Sciences Tehran Iran
1 shared publication - Leila Bayani
Research Development Center Arash Women's Hospital Tehran University of Medical Sciences Tehran Iran
1 shared publication Somayeh Fathi
Advanced Diagnostic and Interventional Radiology Research Center (ADIR) Tehran University of Medical Sciences Tehran Iran
1 shared publication
Latest Publications
- Open Access
- 1 August 2023
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 51 (8) , 1381-1389
Spectrum of ultrasound findings in patients with history of breast conservative treatment
Breast conservative treatment (BCT) is currently accepted as the standard treatment option for breast cancer. Targeted ultrasound helps detect recurrent lesions, postoperative changes, and scarring tissue. In this pictorial essay, we review the ultrasound features of benign (seroma, hematoma, fat necrosis, traumatic neuroma, fibrosis/scarring) and malignant (recurrence, new primary cancer) causes of palpable lumps after BCT and provide images from our patients to illustrate some typical findings of common pathologies. Ultrasound, especially as an adjunct to mammography, can make a specific diagnosis in most cases.
- 1 August 2023
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 51 (8) , 1381-1389
Open AccessSpectrum of ultrasound findings in patients with history of breast conservative treatment
Breast conservative treatment (BCT) is currently accepted as the standard treatment option for breast cancer. Targeted ultrasound helps detect recurrent lesions, postoperative changes, and scarring tissue. In this pictorial essay, we review the ultrasound features of benign (seroma, hematoma, fat necrosis, traumatic neuroma, fibrosis/scarring) and malignant (recurrence, new primary cancer) causes of palpable lumps after BCT and provide images from our patients to illustrate some typical findings of common pathologies. Ultrasound, especially as an adjunct to mammography, can make a specific diagnosis in most cases.